Benjamin Porter-Brown
Impact in
- Rheumatology top 5%
- Rheumatoid Arthritis Research and Therapies
- Spondyloarthritis Studies and Treatments
-
- Cytokine Signaling Pathways and Interactions
Papers in
-
- Rheumatoid Arthritis Research and Therapies 6
- Spondyloarthritis Studies and Treatments 1
-
- Autoimmune and Inflammatory Disorders Research 2
- Co-authors
- Maxime Dougados (1 shared paper)Joachim Sieper (1 shared paper)Olivier Harari (1 shared paper)Anthony I. Sebba (3 shared papers)Andrea Rubbert‐Roth (3 shared papers)Ronald van Vollenhoven (3 shared papers)Pavel Napalkov (3 shared papers)Francis Donaldson (2 shared papers)
- Journals
- Lara D. Veeken (2 papers)Seminars in Arthritis and Rheumatism (1 paper)The Journal of Rheumatology (1 paper)Arthritis & Rheumatology (1 paper)European Journal of Clinical Investigation (1 paper)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Benjamin Porter-Brown
9 papers receiving 403 citations
Peers
Comparison fields: 5 of 33
- Rheumatology 260
- Oncology 42
- Hematology 22
- Immunology 28
- Infectious Diseases 25
Countries citing papers authored by Benjamin Porter-Brown
This map shows the geographic impact of Benjamin Porter-Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Porter-Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Porter-Brown more than expected).
Fields of papers citing papers by Benjamin Porter-Brown
This network shows the impact of papers produced by Benjamin Porter-Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Porter-Brown. The network helps show where Benjamin Porter-Brown may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin Porter-Brown, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 175 | |
| 2 | 2016 | 74 | |
| 3 | 2016 | 49 | |
| 4 | 2017 | 43 | |
| 5 | 2014 | 42 | |
| 6 | 2019 | 15 | |
| 7 | Tofacitinib (cp-690,550), an oral Janus Kinase Inhibitor: Pooled phase 3 analysis in an Australian Rheumatoid Arthritis Study Population | 2012 | 8 |
| 8 | 2014 | 6 | |
| 9 | 2014 | 3 |
About Benjamin Porter-Brown
Benjamin Porter-Brown is a scholar working on Rheumatology, Hematology, Toxicology, Immunology and Nuclear Energy and Engineering, having authored 9 papers that have together received 415 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (6 papers), Autoimmune and Inflammatory Disorders Research (2 papers), Immunotoxicology and immune responses (1 paper), Pharmacovigilance and Adverse Drug Reactions (1 paper) and Spondyloarthritis Studies and Treatments (1 paper). The work is most often cited by research in Rheumatology (260 citations), Oncology (42 citations), Hematology (22 citations), Immunology (28 citations) and Infectious Diseases (25 citations). Benjamin Porter-Brown has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Maxime Dougados, Joachim Sieper, Olivier Harari, Anthony I. Sebba, Andrea Rubbert‐Roth, Ronald van Vollenhoven, Pavel Napalkov, Francis Donaldson, Mark C. Genovese and Sophie Dimonaco. Their work appears in journals such as Lara D. Veeken, Seminars in Arthritis and Rheumatism, The Journal of Rheumatology, Arthritis & Rheumatology and European Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.